Becker Bruno, Gobom Johan, Brinkmalm Gunnar, Andreasson Ulf, Meda Francisco J, Zetterberg Henrik, Blennow Kaj
Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, S-43180 Mölndal, Sweden.
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, S-43180 Mölndal, Sweden.
Brain Commun. 2025 Apr 2;7(2):fcaf129. doi: 10.1093/braincomms/fcaf129. eCollection 2025.
The quantification of neurofilament light polypeptide (NFL) in biofluids is being clinically used to detect and grade general neuronal damage in neurodegenerative diseases and quantify neuronal injury during acute events like traumatic brain injury. Specific assays that target only particular molecular breakdown products of neurofilaments have the potential to distinguish between various pathologies. Nevertheless, the molecular structure of neurofilament light polypeptide in cerebrospinal fluid remains to be elucidated. We characterized neurofilament light polypeptide in cerebrospinal fluid by size-exclusion chromatography, Western blotting and mass spectrometry. Neurofilament light polypeptide in cerebrospinal fluid was found to be composed of aggregates of fragments of the full-length molecule. These aggregates were sensitive to reduction by dithiothreitol and dissociated to monomeric fragments of 6-12 kDa (Western blot), covering most of the coiled-coil domains of neurofilament light polypeptide. Since only cysteine residues can form disulfide bonds, this points to a role of the single cysteine 322 for maintaining the stability of the aggregates. The sequence region covered by the identified fragments ended just a few amino acids C-terminally of the coiled-coil region at a site which had been previously mapped to a calpain cleavage site in the glial fibrillary acidic protein, which is highly homologous to neurofilament light polypeptide in the coiled-coil region. This cleavage site was also confirmed to be present in bovine neurofilament light polypeptide by digestion of purified neurofilament light polypeptide with calpain-1. The difference of the molecular weights of the reduced and non-reduced forms of neurofilament light polypeptide suggests that neurofilament light polypeptide in CSF consists of disulfide-linked aggregated fragments, most likely tetramers, or alternately dimers in a complex with another binding partner.
生物流体中神经丝轻链多肽(NFL)的定量分析已被临床用于检测神经退行性疾病中的一般神经元损伤并进行分级,以及量化创伤性脑损伤等急性事件中的神经元损伤。仅针对神经丝特定分子分解产物的特异性检测方法有潜力区分各种病理情况。然而,脑脊液中神经丝轻链多肽的分子结构仍有待阐明。我们通过尺寸排阻色谱、蛋白质免疫印迹和质谱对脑脊液中的神经丝轻链多肽进行了表征。发现脑脊液中的神经丝轻链多肽由全长分子片段的聚集体组成。这些聚集体对二硫苏糖醇的还原敏感,并解离为6 - 12 kDa的单体片段(蛋白质免疫印迹),覆盖了神经丝轻链多肽的大部分卷曲螺旋结构域。由于只有半胱氨酸残基可以形成二硫键,这表明单个半胱氨酸322在维持聚集体稳定性方面发挥作用。已鉴定片段覆盖的序列区域在卷曲螺旋区域的C末端仅几个氨基酸处结束,该位点先前已被定位到与神经丝轻链多肽卷曲螺旋区域高度同源的胶质纤维酸性蛋白中的钙蛋白酶切割位点。通过用钙蛋白酶-1消化纯化的神经丝轻链多肽,也证实了该切割位点存在于牛神经丝轻链多肽中。神经丝轻链多肽还原形式和非还原形式分子量的差异表明,脑脊液中的神经丝轻链多肽由二硫键连接的聚集片段组成,很可能是四聚体,或者是与另一个结合伴侣形成复合物的二聚体。